In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

about

Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).

P2860

Q43540910-8FD13822-5D00-4DBB-80B0-DC6647DB2048

P2860

In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

Item

http://www.wikidata.org/entity/Q38713074

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

@en

type

Item

label

In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

@en

prefLabel

In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

@en

P1476

In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

@en

P2093

F Peter Guengerich

http://www.w3.org/2001/XMLSchema#string

Kevin M Johnson

http://www.w3.org/2001/XMLSchema#string

Natalia Mast

http://www.w3.org/2001/XMLSchema#string

Thanh T N Phan

http://www.w3.org/2001/XMLSchema#string

P2860

cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain

Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain

Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain

Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation

SwissDock, a protein-small molecule docking web service based on EADock DSS

Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus.

In Silico and Intuitive Predictions of CYP46A1 Inhibition by Marketed Drugs with Subsequent Enzyme Crystallization in Complex with Fluvoxamine

Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1: UNUSUAL FEATURES AND SPECTRAL RESPONSE

Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1

Crystal structure of substrate-free Pseudomonas putida cytochrome P-450

P304

12934-12946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M117.794909

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

Kyle W. Anderson

Irina A Pikuleva

P577

2017-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28642370

http://www.w3.org/2001/XMLSchema#string

P932

5546033

http://www.w3.org/2001/XMLSchema#string

In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

about

P2860

P2860

In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932